Literature DB >> 20633536

The tail domain of tomosyn controls membrane fusion through tomosyn displacement by VAMP2.

Yasunori Yamamoto1, Kohei Fujikura, Mio Sakaue, Kenjiro Okimura, Yuta Kobayashi, Toshihiro Nakamura, Toshiaki Sakisaka.   

Abstract

Neurotransmitter release is regulated by SNARE complex-mediated synaptic vesicle fusion. Tomosyn sequesters target SNAREs (t-SNAREs) through its C-terminal VAMP-like domain (VLD). Cumulative biochemical results suggest that the tomosyn-SNARE complex is so tight that VAMP2 cannot displace tomosyn. Based on these results, the tomosyn-SNARE complex has been believed to be a dead-end complex to inhibit neurotransmitter release. On the other hand, some studies using siRNA depletion of tomosyn suggest that tomosyn positively regulates exocytosis. Therefore, it is still controversial whether tomosyn is a simple inhibitor for neurotransmitter release. We recently reported that the inhibitory activity of tomosyn is regulated by the tail domain binding to the VLD. In this study, we employed the liposome fusion assay in order to further understand modes of action of tomosyn in detail. The tail domain unexpectedly had no effect on binding of the VLD to t-SNARE-bearing liposomes. Nonetheless, the tail domain decreased the inhibitory activity of the VLD on the SNARE complex-mediated liposome fusion. These results indicate that the tail domain controls membrane fusion through tomosyn displacement by VAMP2. Deletion of the tail domain-binding region in the VLD retained the binding to t-SNAREs and promoted the liposome fusion. Together, we propose here a novel mechanism of tomosyn that controls synaptic vesicle fusion positively by serving as a placeholder for VAMP2. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633536     DOI: 10.1016/j.bbrc.2010.07.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Tomosyn inhibits synaptotagmin-1-mediated step of Ca2+-dependent neurotransmitter release through its N-terminal WD40 repeats.

Authors:  Yasunori Yamamoto; Sumiko Mochida; Naoyuki Miyazaki; Katsuhisa Kawai; Kohei Fujikura; Takao Kurooka; Kenji Iwasaki; Toshiaki Sakisaka
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  The N- and C-terminal domains of tomosyn play distinct roles in soluble N-ethylmaleimide-sensitive factor attachment protein receptor binding and fusion regulation.

Authors:  Haijia Yu; Shailendra S Rathore; Daniel R Gulbranson; Jingshi Shen
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

3.  Structural and functional analysis of tomosyn identifies domains important in exocytotic regulation.

Authors:  Antionette L Williams; Noa Bielopolski; Daphna Meroz; Alice D Lam; Daniel R Passmore; Nir Ben-Tal; Stephen A Ernst; Uri Ashery; Edward L Stuenkel
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

4.  Kinetic barriers to SNAREpin assembly in the regulation of membrane docking/priming and fusion.

Authors:  Feng Li; Neeraj Tiwari; James E Rothman; Frederic Pincet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

Review 5.  Molecular underpinnings of synaptic vesicle pool heterogeneity.

Authors:  Devon C Crawford; Ege T Kavalali
Journal:  Traffic       Date:  2015-04       Impact factor: 6.215

6.  Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.

Authors:  Qiuyu Zhu; Munekazu Yamakuchi; Sara Ture; Maria de la Luz Garcia-Hernandez; Kyung Ae Ko; Kristina L Modjeski; Michael B LoMonaco; Andrew D Johnson; Christopher J O'Donnell; Yoshimi Takai; Craig N Morrell; Charles J Lowenstein
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

7.  Neuron-specific expression of tomosyn1 in the mouse hippocampal dentate gyrus impairs spatial learning and memory.

Authors:  Boaz Barak; Eitan Okun; Yoav Ben-Simon; Ayal Lavi; Ronit Shapira; Ravit Madar; Yue Wang; Eric Norman; Anton Sheinin; Mario A Pita; Ofer Yizhar; Mohamed R Mughal; Edward Stuenkel; Henriette van Praag; Mark P Mattson; Uri Ashery
Journal:  Neuromolecular Med       Date:  2013-03-22       Impact factor: 3.843

8.  Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion.

Authors:  Sushant Bhatnagar; Angie T Oler; Mary E Rabaglia; Donald S Stapleton; Kathryn L Schueler; Nathan A Truchan; Sara L Worzella; Jonathan P Stoehr; Susanne M Clee; Brian S Yandell; Mark P Keller; Debbie C Thurmond; Alan D Attie
Journal:  PLoS Genet       Date:  2011-10-06       Impact factor: 5.917

9.  Tomosyn interacts with the SUMO E3 ligase PIASγ.

Authors:  Cornelia J Geerts; Linda Jacobsen; Rhea van de Bospoort; Matthijs Verhage; Alexander J A Groffen
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

10.  Tomosyn associates with secretory vesicles in neurons through its N- and C-terminal domains.

Authors:  Cornelia J Geerts; Roberta Mancini; Ning Chen; Frank T W Koopmans; Ka Wan Li; August B Smit; Jan R T van Weering; Matthijs Verhage; Alexander J A Groffen
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.